🇺🇸 FDA
Patent

US 10036019

Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom

granted A61PA61P31/12

Quick answer

US patent 10036019 (Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P31/12